Related Experiment Video
Updated: Jan 23, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression
Xin Li1,2, Penghe Yang1,3, Tianshi Wang4
1Xinxiang Key Laboratory of Tumor Migration and Invasion Precision Medicine, School of Medical Technology, Xinxiang Medical University, Xinxiang, Henan Province, PR China.
Abstract:
The hyper-activation of the Hippo/YAP axis was observed in triple-negative breast cancer (TNBC), which was crucial for tumor progression. The over-activation of YAP in TNBC remains unexplained, despite the continued functionality of the inhibitory phospho-cascade. Recently, studies revealed that the ubiquitin modifications of YAP also play important roles in the Hippo/YAP axis and cancer progression. In order to understand the potential mechanisms of ubiquitination and deubiquitination process in YAP function, we carried out siRNA screening for critical deubiquitinases in TNBC. Via the deubiquitinases (DUB) library, we identified Ubiquitin Specific Peptidase 8 (USP8) as an important effector in YAP function and TNBC progression. Inhibition of USP8 hampered TNBC progression via Hippo signaling. Clinical data revealed that USP8 expression correlated with YAP protein level and poor survival in TNBC patients. Biochemical evaluations revealed that USP8 has the ability to connect with YAP and suppress K48-linked polyubiquitination, thereby enhancing the stability of YAP. Interestingly, YAP directly binds to the USP8 promoter region, enhancing its transcription in TNBC. Our study revealed a forward feedback loop between USP8 and Hippo signaling in TNBC, indicating USP8 as a potential therapeutic drug targets in TNBC.
Insights
Ubiquitin Specific Peptidase 8 (USP8) stabilizes YAP, promoting triple-negative breast cancer (TNBC) progression. Inhibiting USP8 halts TNBC growth, suggesting USP8 as a potential therapeutic target for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The Hippo/Yao (YAP) signaling pathway is hyperactivated in triple-negative breast cancer (TNBC), driving tumor progression.
- While the inhibitory phospho-cascade remains functional, the over-activation of YAP in TNBC is not fully understood.
- Ubiquitin modifications of YAP are increasingly recognized for their role in cancer progression.
Purpose of the Study:
- To investigate the mechanisms of ubiquitination and deubiquitination in YAP function within TNBC.
- To identify critical deubiquitinating enzymes (DUBs) involved in YAP regulation in TNBC.
- To explore the therapeutic potential of targeting DUBs in TNBC.
Main Methods:
- Conducted siRNA screening using a deubiquitinase (DUB) library to identify key DUBs affecting YAP.
- Performed biochemical assays to elucidate the interaction between USP8 and YAP.
- Analyzed clinical data to correlate USP8 expression with patient survival and YAP protein levels in TNBC.
Main Results:
- Identified Ubiquitin Specific Peptidase 8 (USP8) as a crucial effector in YAP function and TNBC progression.
- Demonstrated that USP8 inhibition significantly hampered TNBC progression by modulating Hippo signaling.
- Found that USP8 directly binds to the YAP promoter, enhancing its transcription and establishing a positive feedback loop.
Conclusions:
- USP8 enhances YAP stability by suppressing K48-linked polyubiquitination, contributing to TNBC progression.
- A positive feedback loop exists between USP8 and Hippo signaling in TNBC.
- USP8 represents a promising therapeutic target for treating triple-negative breast cancer.
Related Concept Videos
Positive and Negative Feedback Loops
Positive Regulator Molecules
Positive Regulator Molecules
Negative Regulator Molecules
Positive, Negative, and Zero Work
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...

